- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07469644
A Digital Mindfulness Intervention to Improve Sleep Efficiency and Heart Rate Variability in Healthy Adults
March 10, 2026 updated by: University of Southern Denmark
A Digital Mindfulness Intervention to Improve Sleep Efficiency and Heart Rate Variability in Healthy Adults: A Randomized Waitlist-Controlled Trial
This study tested whether a 10-day smartphone app-based mindfulness program can improve sleep and reduce physiological stress in healthy adults.
Eighty-one healthy adults were randomly assigned to either a mindfulness group (completing a daily 10-minute guided session via the Ōura app for 10 days) or a waitlist control group.
All participants wore an Ōura Ring throughout the study to objectively measure sleep and heart rate variability (HRV).
Questionnaires on perceived stress, sleep quality, burnout, and mindfulness were completed before, immediately after, and four weeks after the intervention.
The study was conducted at the University of Southern Denmark.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This randomized controlled trial (RCT) used a waitlist-controlled design to examine whether a 10-day smartphone app-based mindfulness program could improve sleep and reduce physiological stress markers in healthy adults.
The study was embedded within a broader 4-month longitudinal cohort study (N=140); the RCT sub-study focused on participants in the low-stress stratum (Perceived Stress Scale [PSS-10] ≤13) at screening.
Participants (n=81) were randomized in approximately a 3:2 ratio to either a mindfulness intervention group (n=49) or a waitlist control group (n=32).
The mindfulness group completed one 10-minute guided audio session daily ("destress" module, narrated by Headspace) delivered via the Ōura app for 10 consecutive days in free-living conditions at a time of their own choosing.
Compliance was monitored objectively via app-recorded session timestamps.
The waitlist control group wore the Ōura Ring and completed all questionnaires identically without receiving any intervention.
All participants wore an Ōura Ring Gen 3 throughout the study to objectively and continuously measure sleep architecture, sleep efficiency, and heart rate variability (HRV).
Self-report questionnaires on perceived stress (Perceived Stress Scale; PSS-10), sleep quality (Pittsburgh Sleep Quality Index; PSQI), burnout (Copenhagen Burnout Inventory; CBI), and mindful attention (Mindful Attention Awareness Scale; MAAS) were administered before, immediately after, and four weeks after the 10-day intervention period.
The study was conducted at the University of Southern Denmark, Odense, Denmark.
Study Type
Interventional
Enrollment (Actual)
91
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Odense, Denmark, 5230
- University of Southern Denmark. Department of Psychology.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Adults aged 20-60 years
- Body mass index (BMI) in normal range (18.5-29.9 kg/m²)
- Low stress at screening (Perceived Stress Scale (PSS-10) score ≤13)
- Willingness to wear the Ōura Ring continuously throughout the study
- No current regular mindfulness practice (defined as >20 min/week)
- Ability to provide written informed consent
- Sufficient Danish or English language proficiency
Exclusion Criteria:
- Current regular mindfulness or meditation practice >20 min/week
- Self-reported diagnosis of cardiovascular or neurodegenerative disease
- Current diagnosis of anxiety or depressive disorder
- Use of psychotropic medications, hypnotics, or medications affecting heart rate variability (HRV) or sleep
- Pregnancy
- Shift work or highly irregular sleep schedules
- Concurrent participation in another mindfulness or behavioral sleep intervention
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mindfulness Intervention
Participants completed a 10-day app-based mindfulness program (one 10-min guided session/day via Ōura app) in free-living conditions.
|
Participants completed one 10-minute guided audio mindfulness session daily ("destress" module, narrated by Headspace) delivered via the Ōura app for 10 consecutive days in free-living conditions at a time of their own choosing.
Compliance was monitored objectively via app session timestamps.
|
|
No Intervention: Waitlist Control
Participants wore the Ōura Ring and completed all assessments without receiving any intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sleep Efficiency
Time Frame: Pre-intervention (Time 0: 7-day average immediately before Day 1); post-intervention (Time 1: 7-day average immediately after Day 10); 4-week follow-up (Time 2: days 22-28 of follow-up)
|
Percentage of time asleep relative to total time in bed, measured continuously by Ōura Ring Gen 3 (accelerometry and photoplethysmography); computed as 7-day averages at each assessment timepoint.
|
Pre-intervention (Time 0: 7-day average immediately before Day 1); post-intervention (Time 1: 7-day average immediately after Day 10); 4-week follow-up (Time 2: days 22-28 of follow-up)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total Sleep Time
Time Frame: Pre-intervention (Time 0: 7-day average immediately before Day 1); post-intervention (Time 1: 7-day average immediately after Day 10); 4-week follow-up (Time 2: days 22-28 of follow-up)
|
Minutes asleep per night, measured by Ōura Ring Gen 3.
|
Pre-intervention (Time 0: 7-day average immediately before Day 1); post-intervention (Time 1: 7-day average immediately after Day 10); 4-week follow-up (Time 2: days 22-28 of follow-up)
|
|
Deep Sleep Duration
Time Frame: Pre-intervention (Time 0: 7-day average immediately before Day 1); post-intervention (Time 1: 7-day average immediately after Day 10); 4-week follow-up (Time 2: days 22-28 of follow-up)
|
Minutes of slow-wave sleep per night, measured by Ōura Ring Gen 3.
|
Pre-intervention (Time 0: 7-day average immediately before Day 1); post-intervention (Time 1: 7-day average immediately after Day 10); 4-week follow-up (Time 2: days 22-28 of follow-up)
|
|
Light Sleep Duration
Time Frame: Pre-intervention (Time 0: 7-day average immediately before Day 1); post-intervention (Time 1: 7-day average immediately after Day 10); 4-week follow-up (Time 2: days 22-28 of follow-up)
|
Minutes of non-rapid eye movement (NREM) light sleep per night, measured by Ōura Ring Gen 3.
|
Pre-intervention (Time 0: 7-day average immediately before Day 1); post-intervention (Time 1: 7-day average immediately after Day 10); 4-week follow-up (Time 2: days 22-28 of follow-up)
|
|
Sleep Onset Time
Time Frame: Pre-intervention (Time 0: 7-day average immediately before Day 1); post-intervention (Time 1: 7-day average immediately after Day 10); 4-week follow-up (Time 2: days 22-28 of follow-up)
|
Clock time of sleep onset, measured by Ōura Ring Gen 3.
|
Pre-intervention (Time 0: 7-day average immediately before Day 1); post-intervention (Time 1: 7-day average immediately after Day 10); 4-week follow-up (Time 2: days 22-28 of follow-up)
|
|
Heart Rate Variability (HRV)
Time Frame: Daily during 10-day intervention period
|
Root mean square of successive differences (RMSSD) (ms) measured during 10-min mindfulness sessions compared to an equivalent pre-session baseline period, assessed by Ōura Ring Gen 3.
|
Daily during 10-day intervention period
|
|
Perceived Stress Scale (PSS-10)
Time Frame: Pre-intervention (Time 0: 7-day average immediately before Day 1); post-intervention (Time 1: 7-day average immediately after Day 10); 4-week follow-up (Time 2: days 22-28 of follow-up)
|
Perceived Stress Scale (PSS-10).
Self-report questionnaire; sum score 0-40.
|
Pre-intervention (Time 0: 7-day average immediately before Day 1); post-intervention (Time 1: 7-day average immediately after Day 10); 4-week follow-up (Time 2: days 22-28 of follow-up)
|
|
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: Pre-intervention (Time 0: 7-day average immediately before Day 1); post-intervention (Time 1: 7-day average immediately after Day 10); 4-week follow-up (Time 2: days 22-28 of follow-up)
|
Pittsburgh Sleep Quality Index (PSQI).
Self-report questionnaire; global score 0-21.
|
Pre-intervention (Time 0: 7-day average immediately before Day 1); post-intervention (Time 1: 7-day average immediately after Day 10); 4-week follow-up (Time 2: days 22-28 of follow-up)
|
|
Copenhagen Burnout Inventory (CBI)
Time Frame: Pre-intervention (Time 0: 7-day average immediately before Day 1); post-intervention (Time 1: 7-day average immediately after Day 10); 4-week follow-up (Time 2: days 22-28 of follow-up)
|
Copenhagen Burnout Inventory (CBI).
Self-report questionnaire; subscale scores 0-100%.
|
Pre-intervention (Time 0: 7-day average immediately before Day 1); post-intervention (Time 1: 7-day average immediately after Day 10); 4-week follow-up (Time 2: days 22-28 of follow-up)
|
|
Mindful Attention Awareness Scale (MAAS)
Time Frame: Pre-intervention (Time 0: 7-day average immediately before Day 1); post-intervention (Time 1: 7-day average immediately after Day 10)
|
Mindful Attention Awareness Scale (MAAS).
Self-report questionnaire; sum score 15-90.
Administered to the mindfulness intervention group only.
|
Pre-intervention (Time 0: 7-day average immediately before Day 1); post-intervention (Time 1: 7-day average immediately after Day 10)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ulrich Kirk, PhD, University of Southern Denmark
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2023
Primary Completion (Actual)
May 1, 2024
Study Completion (Actual)
August 1, 2024
Study Registration Dates
First Submitted
March 3, 2026
First Submitted That Met QC Criteria
March 10, 2026
First Posted (Actual)
March 13, 2026
Study Record Updates
Last Update Posted (Actual)
March 13, 2026
Last Update Submitted That Met QC Criteria
March 10, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- 21345
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
De-identified individual participant data will be made available from the corresponding author (Ulrich Kirk; ukirk@health.sdu.dk) on reasonable request.
Data sharing will comply with the Danish Data Protection Act and General Data Protection Regulation (GDPR) (Regulation EU 2016/679).
IPD Sharing Time Frame
Following publication of primary results
IPD Sharing Access Criteria
Data available upon reasonable request to the corresponding author.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep
-
University of Wisconsin, MadisonPhilips HealthcareCompletedSleep, Slow-wave Sleep, Sleep Enhancement, Sleep Optimization
-
Brain Electrophysiology Laboratory CompanyRecruiting
-
University GhentEuropean CommissionCompleted
-
Mahidol UniversityRamathibodi HospitalNot yet recruitingSleep Inertia | Sleep, Slow-wave Sleep, Sleep Enhancement, Sleep Optimization | Night Shift WorkThailand
-
Northumbria UniversityCompletedSleep | Mood | Poor Quality Sleep | Good Sleep HabitUnited Kingdom
-
Universidade Federal de PernambucoEnrolling by invitationSleep | Obstructive Sleep Apnea (OSA)Brazil
-
Atlas UniversityCompletedSleep | Surgery | Sleep QualityTurkey (Türkiye)
-
Mersin UniversityCompletedSleep Quality | Sleep PerceptionTurkey (Türkiye)
-
Brigham and Women's HospitalNot yet recruitingObstructive Sleep Apnea | Sleep-disordered BreathingUnited States
-
Institute of Nutrition, Slovenia (Nutris)Valens Int. d.o.o., Slovenija; Faculty of Pharmacy, University of Ljubljana... and other collaboratorsNot yet recruitingSleep Quality | Sleep Onset LatencySlovenia
Clinical Trials on App-based mindfulness program (Headspace via Ōura app)
-
Boise State UniversityCase Western Reserve UniversityCompletedDepression | Stress, Psychological | Parents | Chronic Illness | Family DynamicsUnited States
-
University of OttawaNot yet recruitingStress | Burnout, Professional | Depression, Anxiety
-
Kaiser PermanenteAmerican Cancer Society, Inc.CompletedCancer | Distress | Chemotherapy EffectUnited States
-
Northwestern UniversityCompletedDepression | AnxietyUnited States
-
University of Wisconsin, MadisonCompletedInflammation | Systemic Lupus ErythematosusUnited States
-
University College, LondonBritish Heart Foundation; Headspace Meditation Limited; Technical University...UnknownWell-being, Work StressUnited Kingdom
-
Instituto de Investigación Hospital Universitario...CompletedVentricular Fibrillation | Ventricular Tachycardia | Cardiac ArrhythmiaSpain
-
Mclean HospitalCambridge Health Alliance; Lawrence UniversityRecruitingRuminationUnited States
-
MaineHealthSuspendedStress | AnxietyUnited States